应用基因科技公司

AGTC NASDAQ
2.990
-0.010
-0.33%
交易中 09:30 08/22 EDT
开盘
2.990
昨收
3.000
最高
2.990
最低
2.990
成交量
36
成交均量(3M)
7.08万
52周最高
7.50
52周最低
2.260
换手率
0.00%
市值
5,433.22万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供应用基因科技公司 AGTC股票价格,应用基因科技公司股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. The Company develops gene therapy products designed to manage the lives of patients with severe diseases in ophthalmology. As of March 31, 2016, its product candidates included treatments for X-linked retinoschisis (XLRS), over two forms of achromatopsia (ACHM) and X-linked retinitis pigmentosa (XLRP). As of March 31, 2016, the Company was engaged in developing three discovery programs, targeting three indications based on its adeno-associated virus vector technologies. XLRS is an inherited retinal degenerative disease caused by mutations in the retinoschisis1 (RS1) gene. Achromatopsia is an inherited condition that is associated with visual acuity loss, extreme light sensitivity resulting in daytime blindness, and reduced or complete loss of color discrimination, achromatopsia is caused by mutations in any of several genes. The Company is also developing Alpha-1 Antitrypsin Deficiency (Alpha 1).
展开 >

最近浏览

名称
价格
涨跌幅